AmorChem backs human cancers project

Canadian life sciences venture capital firm AmorChem has invested in a c-Myc-driven cancers project with Univalor, Montreal Clinical Research Institute and McGill University.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this